(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
'War is not over': Detailed diagrams of prisons found in cells of Oct. 7 terrorists - 2How a rare drug made from scientists' blood saves babies from botulism
- 3Gaza amputees struggle to rebuild lives as the enclave faces shortages of prosthetic limbs
- 4Dirty soda started as a Mormon alternative to booze. Now it's everywhere.
- 5Wedding trip Objections in the US
- Robert Pattinson claims he's a pathological liar. What 'The Drama' star has said about his 'shtick'
- Politics at the table? Drinking the wine you brought? An etiquette expert's Thanksgiving dos and don'ts.
- Embracing Practical Living and Ecological Protection
- Warnings rise for U.S. as severe flu strain causes outbreaks in Canada, U.K.
- ‘More should be done’: UN pushes Syrian regime on justice for Druze, Alawites and minority groups
- How to watch 'A Charlie Brown Christmas' for free in 2025
- 'Stranger Things' Season 5: What's going on with Will Byers? That shocking Volume 1 plot twist, explained.
- What is ‘Auld Lang Syne’? Why we sing this song at midnight on New Year’s Eve.
- Newly Built Sichuan Hydropower Bridge Collapses Into River Months After Opening
